The Role of Medical Literature, Clinical Trials and Experimental Research in Drug Product-Injury Litigation: A Primer with Two Examples

@inproceedings{Kitzen2018TheRO,
  title={The Role of Medical Literature, Clinical Trials and Experimental Research in Drug Product-Injury Litigation: A Primer with Two Examples},
  author={Jan M. Kitzen and J V Pergolizzi and Robert E. Taylor and Robert B Raffa},
  year={2018}
}
When any type of product has been ordered to be removed from the marketplace by a governmental regulatory body, that action is a powerful indicator that the product has been determined to be unsafe for further use, thereby branding the product as defective and opening up the possibility of product liability litigation. When the product is a drug or medical device, it is especially serious since the possibility of personal injury (acute and/or chronic) or death may occur. Needless to say… CONTINUE READING

Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Valvular heart disease associated with fenfluramine-phentermine.

  • The New England journal of medicine
  • 1997
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Drug Injury Watch

T. Lamb
  • http://www.drug-injury.com/
  • 2018
VIEW 1 EXCERPT

Pharmacology & Pharmacy Evidence-Based Medicine: How to Practice and Teach EBM

D. L. Sackett, S. E. Straus, W. S. Richardson, W. Rosenberg, R. B. Haynes
  • 2018
VIEW 1 EXCERPT

Thimerosal-Autism Link Rejected by Maryland Court

Blackwell
  • v. Sigma Aldrich, Inc
  • 2008
VIEW 1 EXCERPT

The Epidemiology of Autistic Spectrum Disorders : Is the Prevalence Rising ?

A. J. Wakefield, S. H. Murch, A. A. J. Linnell
  • Mental Retardation and Developmental Disabilities Research Reviews
  • 2002